Displaying results 1-10 of 103

• ASBMB Today Article
  ‘Don't just stop at what you’re assigned to do’
  April 14, 2023
  

  Isaac Bell talked to ASBMB Today about his path to and current position at The Jackson Laboratory.
• ASBMB Today Article
  ‘I was in the right place at the right time’
  March 4, 2023
  

  Mark Witmer, a senior director at Bristol Myers Squibb, talked to ASBMB Today about what it’s like to be an industry manager.
• ASBMB Today Article
  What’s it like to work at 23andMe?
  Feb. 10, 2023
  

  With enormous troves of data at their disposal, “we can do things no one else can do,” senior scientist Sarah Laskey said.
• ASBMB Today Article
  ‘I like to be in the lab’
  Dec. 23, 2022
  

  Our industry careers columnist spoke with Susan Abbatiello, a principal consultant scientist at Waters Corp.
• ASBMB Today Article
  What next-gen Covid-19 vaccines might look like
  Dec. 10, 2022
  

  From building up defenses in the nose to slowing down a virus’s ability to make copies of itself, scientists are rolling out a raft of creative approaches to fighting infection.
• ASBMB Today Article
  'Keep developing your expertise'
  Sept. 16, 2022
  

  Anand Balakrishnan is a biochemist at Enanta Pharmaceuticals. He leads a team that has worked on respiratory syncytial virus, SARS-CoV-2 and hepatitis B virus.
• ASBMB Today Article
  Turning points
  Aug. 24, 2022
  

  Eight scientists from academia and industry reflect on how mentors have impacted their lives.
• ASBMB Today Article
  Why are drug names so long and complicated?
  Aug. 20, 2022
  

  A pharmacist explains the logic behind the nomenclature.
• ASBMB Today Article
  ‘I wanted to go where I was needed’
  Aug. 19, 2022
  

  Yuliya McAnany, a senior associate scientist at Amicus Therapeutics, talked to our industry careers columnist about her work.
• ASBMB Today Article
  Parents become drug developers to save their children’s lives
  Aug. 14, 2022
  

  Half of all rare-disease patients are children, and their families have long pushed to speed up cures. Now, some families are forming their own biotech businesses.